News
Krystal Research Published in The Lancet
Data from an early phase clinical trial of a drug being developed for adults living with schizophrenia was published December 15 in The Lancet.
John H. Krystal, MD, Robert L. McNeil, Jr. Professor of Translational Research and professor of psychiatry, of neuroscience, and of psychology, and chair of the Yale Department of Psychiatry, is first author of the study of the drug emraclidine, developed by Cerevel Therapeutics.